Getein Biotech, Inc.  

Product Name: Crp C-Reactionprotein Diagnostic Kits with Ce Model NO.: CG1003 Group: All Men Certification: CE, ISO13485 Type: Poct Reagent Classification: Biological Diagnostics Suitable Instrument: Fia8600/ Fia8000 Trademark: GP Transport Package: Carton Specification: 25 test/Box Origin: Jiangsu HS Code: 3002100090 Product Description The One Step Test for hs-CRP+CRP (colloidal gold)is intended for use together with theFIA8000 Quantitative Immunoassay Analyzer (FIA8000).The product employs colloidal gold immunochromatogrphy to determine hs-CRP+CRP in human serum, plasma, whole blood or fingertip blood specimens. Two monoclonal antibodies are employed to identify hs-CRP+CRP specifically, resulting in a purplish red streak appears on the test line. The color intensity of the test line increases in proportion to the concentrations of hs-CRP+CRP.Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of hs-CRP+CRP is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.DepartmentClinical ApplicationRespirationRespiratory tract infection ,pulmonary infection (bacterial),lung neoplasm,tuberculosis, pulmonary infarction, lung abscess, empyemaPediatricsDiagnosis and identification of various inflammatory or infection diseases of children and infantsGastroenterologyCholecystitis, liver abscess, peritonitis, malignant tumorUrologyPyelonephritis, endonephritis, cystitis, perinephreticAbscess, cancer etcGynecologyClinical detection of normal gynecological inflammation, therapy monitoring of gynecologic surgeryStomatologyPeriodontitis, maxillofacial infection , maxillofacial injuries, implant surgery, ICU, monitoring the nosocomial infections, detection before and after tooth extraction operationOncologyAccessory diagnosis of malignant neoplasm, detection after chemotherapy, clinical detection before or after tumor operationCardiologyDetection of cardiovascular inflammatory lesion, monitoring the prognostic implications of cardiac diseasesOther departmentsCollagenosis, allergic and autoimmune disease activity period (rheumatism, SLE, rheumatoid), infectious disease, sepsis and other malignanciesCompany ProfileGetein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.